论文部分内容阅读
目的观察替米沙坦联合美托洛尔治疗慢性心力衰竭的临床疗效。方法将92例CHF患者随机分为两组,对照组(40例)给予低钠饮食、强心、利尿及扩血管等常规治疗,同时服用美托洛尔片;治疗组(52例)在对照组基础上加服替米沙坦片。比较两组疗效。结果 2组总有效率比较,差异有显著性(P<0.05)。2组HR、SBP、DBP及LVD、LVS、LVEF的变化差异均无统计学意义(P>0.05)。结论替米沙坦联合美托洛尔联合治疗慢性心衰安全有效。
Objective To observe the clinical efficacy of telmisartan and metoprolol in the treatment of chronic heart failure. Methods 92 patients with CHF were randomly divided into two groups. The control group (40 patients) received routine treatment with low sodium diet, cardiac, diuretic and vasodilator while taking metoprolol tablets. The treatment group (52 cases) Based on the group plus telmisartan tablets. Compare the two groups curative effect. Results The total effective rate of the two groups, the difference was significant (P <0.05). There were no significant differences in HR, SBP, DBP, LVD, LVS, LVEF between the two groups (P> 0.05). Conclusion Telmisartan combined with metoprolol in the treatment of chronic heart failure is safe and effective.